300314 Ningbo David Medical Device
- 12.00
- -0.21-1.72%
Ningbo David Medical Device News
David Medical Device's Unit Gets Certificate for Electric Anorectal Stapler
Ningbo David Medical Device (SHE:300314) unit, Ningbo Weirkaidi Medical Equipment, received a medical device registration certificate from the food and drug regulator of China's Zhejiang Province for
David Healthcare (300314.SZ): Valkady products obtained medical device registration certificate
On May 16, Ge Longhui Medical (300314.SZ) announced that the wholly-owned subsidiary of the company, Ningbo Vivacity Medical Devices Co., Ltd. (hereinafter referred to as “Virkaidi”), recently received a “Medical Device Registration Certificate” issued by the Zhejiang Drug Administration to use an electric anorectal stapler for single use.
Express News | David Medical: The wholly-owned subsidiary's product uses a single-use electric anorectal stapler to obtain a medical device registration certificate
David Healthcare (300314.SZ): Net profit of 38.1072 million yuan in the first quarter decreased by 23.81% year-on-year
On April 19, Ge Longhui (300314.SZ) released its report for the first quarter of 2024. Operating income for the reporting period was 155 million yuan, down 1.61% year on year; net profit attributable to shareholders of listed companies was 38.1072 million yuan, down 23.81% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 394.438 million yuan, down 11.14% year on year; basic earnings per share were 0.1323 yuan.
David Medical (300314.SZ): Pediatric obstetrics care equipment has now entered more than 600 of the top three hospitals in China
Gelonghui, April 16 | David Medical (300314.SZ) said at an investor relations event that the company's pediatric obstetrics care equipment has now entered more than 600 domestic hospitals, has agents in more than 30 provinces, cities and autonomous regions, and provides technology, products and services to more than 140 countries and regions around the world; the company's minimally invasive surgical instruments have entered more than 400 domestic hospitals, and the foreign market covers 83 countries and regions. Currently, there are a total of 29 research projects. For details, please refer to the company's 2023 report.
Open Source Securities released a research report on April 10 stating that it gave David Healthcare (300314.SZ) a purchase rating. The main reasons for the rating include: 1) Endoscopy and electrification of staplers are already popular, and the collectio
Open Source Securities released a research report on April 10 stating that it gave David Healthcare (300314.SZ) a purchase rating. The main reasons for the rating include: 1) Endoscopy and electrification of staplers are already popular, and the collection policy is expected to increase the penetration rate and localization rate of electric kettles; 2) the subsidiary Vilkady uses the power of harvesting to speed up the release of staplers and forward-looking layout of first aid products. (Mainichi Keizai Shimbun)
David Healthcare (300314.SZ) announced its 2023 annual results, with net profit of 148 million yuan, an increase of 51.62%
David Healthcare (300314.SZ) released its 2023 annual report. The company's revenue was 618 million yuan, an increase of 22.18% over the previous year. Net profit attributable to shareholders of listed companies was 148 million yuan, an increase of 51.62% over the previous year. Net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was $129 million, an increase of 61.78% over the previous year. Basic earnings per share were $0.51.
David Healthcare (300314.SZ): As of February 29, 2024, the total number of shareholders of the company is about 16,300
On March 5, Ge Longhui | David Healthcare (300314.SZ) said on the investor interactive platform that as of February 29, 2024, the total number of shareholders of the company was about 16,300.
David Medical (300314.SZ): Currently, Vercady endoscopic staplers have entered more than 300 domestic hospitals
On March 5, Ge Longhui | David Medical (300314.SZ) said on the investor interactive platform that at present, Virkaidi endoscopic staplers have entered more than 300 domestic hospitals, mainly in the top three hospitals.
David Healthcare (300314.SZ): Wholly-owned subsidiary's application for medical device registration accepted
Gelonghui, Feb. 1, Davie Medical (300314.SZ) announced that Ningbo Vivacity Medical Devices Co., Ltd. (“Vercedi”), a wholly-owned subsidiary of the company, recently obtained 2 “Acceptance Notices” issued by the Zhejiang Drug Administration. The acceptance numbers are: 20244003283 for drug acceptance and 20244003467 for drug acceptance.
Express News | David Healthcare: Net profit is expected to increase 40%-60% year-on-year in 2023
David Healthcare (300314.SZ): As of January 10, 2024, the total number of shareholders of the company is about 16,000
On January 12, Ge Longhui | David Healthcare (300314.SZ) said on the investor interactive platform that as of January 10, 2024, the total number of shareholders of the company was about 16,000.
David Healthcare (300314.SZ) and Valkydy passed the high-tech enterprise certification
Gelonghui, December 29丨David Medical (300314.SZ) announced that the company and its wholly-owned subsidiary Ningbo Vierkaidi Medical Devices Co., Ltd. (“Velkady”) received the “Notice on the Filing of the First Batch of High-tech Enterprises in the 2023 Accreditation Report” issued by the National High-tech Enterprise Certification and Management Leading Group Office. The company and Welkady were recognized as high-tech enterprises. The certificate numbers are GR202333102141 and GR202333102669, respectively. The certificate numbers are GR202333102669, respectively. May 8th, valid for three years
David Medical (300314.SZ) subsidiary obtains “disposable circumcision stapler” medical device registration certificate
David Medical (300314.SZ) issued an announcement. Ningbo Welkaidi Medical Devices Co., Ltd., a wholly-owned subsidiary of the company...
David Healthcare (300314.SZ) subsidiary's application for a medical device registration was accepted
David Medical (300314.SZ) announced that Ningbo Wilkedi Medical Devices Co., Ltd., a wholly-owned subsidiary of the company (simplified...
David Healthcare (300314.SZ): At present, the company's overseas business has achieved steady development
Gelonghui, November 22|David Healthcare (300314.SZ) recently stated during a survey from institutional investors that at present, the company's overseas business has achieved steady development, and will continue to pay attention to the expansion of overseas business in the future, taking into account the market development of the industry and its own actual situation, and actively develop related business overseas layout.
David Healthcare (300314.SZ) released results for the first three quarters, with net profit of 123 million yuan, an increase of 61.70%
David Healthcare (300314.SZ) released its report for the third quarter of 2023, and achieved revenue of 4.5 in the first three quarters...
[Instant Analysis of BT Financial Report] David Healthcare 2023 Interim Report: Revenue and Net Profit Increased Sharply, and Cash Flow Performance Remarkable
David Healthcare (stock code: 300314)'s 2023 interim report has been published. From this, we can see the company's performance in various financial data. First, let's take a look at David Healthcare's revenue. Revenue for the reporting period was 317,308,737.59 yuan, an increase of 51.82% compared to 209,007,798.26 yuan after adjustments for the same period last year. This indicates that the company's business scale is expanding, and its market share is likely to increase. Next, let's take a look at David Healthcare's net profit. Net profit attributable to shareholders of listed companies for the reporting period was 91,7
David Healthcare (300314.SZ): Wilkady obtained 1 medical device registration certificate
GLONGHUI, September 1: David Medical (300314.SZ) announced that Ningbo Welkaidi Medical Devices Co., Ltd. (“Welkaidi” for short), a wholly-owned subsidiary of the company, recently received a “Medical Device Registration Certificate” issued by the State Drug Administration. It is a linear cutting stapler for single-use electric endoscopes.
David Healthcare (300314) Company Review: Childcare Business Greatly Exceeds Expectations, Collection and Landing Boosts Stapler Release
Incident On August 22, 2023, the company released the 2023 semi-annual report. During the reporting period, the company achieved operating income of 317 million yuan, an increase of 51.82% over the previous year; net profit of Gimu was 91.78 million yuan, an increase over the previous year
Analysis
Price Target
No Data
